MilliporeSigma

In September and October, we proudly celebrated the rich heritage of our Latino/Hispanic colleagues. Our Employee Resource Group, HOLA, is leading the way across Merck KGaA, Darmstadt, Germany with initiatives to honor #HispanicHeritageMonth in the U.S. and beyond. Sebastián Arana A., Alessandra Richardson, PhD, CMPP, Andrea Valencia, Global EMBA EMD Serono EMD Electronics

Hear from experts Melisa Wilson and Alexandra Fajardo as they explain biosafety testing, why it's essential in drug production, and how the opening of our new Rockville biosafety testing site will help foster even faster innovations.

Join us on LinkedIn for a live and interactive panel discussion to explore the future of ADCs in cancer treatment. The discussion will focus on recent advancements in technology and integration with other therapies. Key topics will include innovations in antibody engineering, linker chemistry, payload selection, the role of biomarkers, and challenges in manufacturing. This event is an excellent opportunity for experts, researchers, clinicians, and industry professionals to gain insights into the latest developments and future directions of ADCs. Click Attend to RSVP.

Test yourself! One challenge drug makers face is the poor solubility of active pharmaceutical ingredients (APIs). When taken by a patient, the API within the drug product should be soluble, meaning it should absorb into the body. And yet, 70% of drugs in development are poorly soluble. Knowing this, which of the below techniques do drug makers use to combine API with one or more compounds to overcome solubility challenges? Hint: Find out how our AI-based mPredict service can expedite your drug development process and help you overcome solubility issues. https://ms.spr.ly/6043mNhpS?

Join us next week for an interactive discussion on the future of ADCs in cancer treatment! Our panel of experts will cover advancements in antibody engineering, linker chemistry, biomarkers, and more. Register for the free event here: https://ms.spr.ly/6048mIL6y

BIG news! We just opened our new €290 million biosafety testing facility in Rockville, USA. Our largest biosafety testing investment ever, the new space will help ensure the medicines we take are safe and effective. This new hub brings our testing teams in Rockville together into a single facility, fostering even more innovation, faster. The space enables advances in automation and digitalization and features novel solutions like the Blazar CHO Animal Origin Free panel, cutting viral test timelines by 60%. Read how we are ensuring the safety of the world's medicines for patients here: https://ms.spr.ly/6041mx9kX

Ever since our first drop of lab water, we’ve continued to look for ways to make our Milli-Q lab water systems even better.??

Stay tuned! We are announcing something BIG in two days.

70% of drugs in development suffer from poor solubility, impacting their ability to be formulated. The solution? AI and Co-crystallization. Crystallizing a drug compound with a co-former can drastically improve solubility, but identifying the optimal co-former takes time and resources. Find out how David Lüdeker is supporting scientists by harnessing the power of AI to accelerate drug formulation.

?? Are you smarter than an 11-year-old? At the 2024 Curiosity Cube, students are diving into sustainability by exploring the life cycle of a T-shirt—from the materials used to the production processes that impact our planet. By the time they leave, they have learned about sustainable choices and can answer this question. Can you?